LungLife AI (LSE:LLAI) Accounts Payable : £0.22 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Accounts Payable?

LungLife AI's Accounts Payable for the quarter that ended in Jun. 2024 was £0.22 Mil.

LungLife AI's quarterly Accounts Payable increased from Jun. 2023 (£0.29 Mil) to Dec. 2023 (£0.35 Mil) but then declined from Dec. 2023 (£0.35 Mil) to Jun. 2024 (£0.22 Mil).

LungLife AI's annual Accounts Payable increased from Dec. 2021 (£0.16 Mil) to Dec. 2022 (£0.29 Mil) and increased from Dec. 2022 (£0.29 Mil) to Dec. 2023 (£0.35 Mil).

LungLife AI Accounts Payable Historical Data

The historical data trend for LungLife AI's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI Accounts Payable Chart

LungLife AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.40

0.59

0.16

0.29

0.35

LungLife AI Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable	Get a 7-Day Free Trial						0.30	0.29	0.29	0.35	0.22

LungLife AI Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

LungLife AI Accounts Payable Related Terms

Thank you for viewing the detailed overview of LungLife AI's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

LungLife AI Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320

Website

https://www.lunglifeai.com

LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.

LungLife AI Headlines

No Headlines